Centre for Probe Development and Commercialization

AtomVie Opens $160M Radiopharma Plant in Hamilton, Ontario

Hamilton, Ontario – – September 10, 2026 -- AtomVie Global Radiopharma has officially opened a new manufacturing plant at 10 Aeropark Boulevard in Hamilton, Ontario, representing an investment exceeding $160 million and marking the largest contract development and manufacturing organization (CDMO) site in North America dedicated to radiopharmaceutical production.

Facility spans 6,700 square meters and multiplies output tenfold

The site covers more than 6,700 square meters and increases AtomVie's production capacity by more than tenfold, supporting variable low-to-high throughput manufacturing. Modular spaces are designed to allow a smooth transition from early-stage clinical development to full commercial-scale production of radiopharmaceuticals.

AtomVie Opens $160M Radiopharma Plant, 10x Capacity in Ontario

Hamilton, Ontario – September 10, 2026 -- AtomVie Global Radiopharma has opened a new 72,300-square-foot production facility at 10 Aeropark Boulevard in Hamilton, Ontario, backed by more than $160 million in investment and marking the largest single-site radiopharmaceutical CDMO facility in North America.

New facility multiplies AtomVie's manufacturing output tenfold

The purpose-built plant increases AtomVie's production capacity by a factor of ten, supporting both low- and high-throughput manufacturing. The site is designed to handle the full lifecycle of radiopharmaceutical production, from early-stage clinical development through commercial-scale manufacturing, with flexible space reserved for future client requirements.

AtomVie Opens $160M Radiopharma Plant, North America's Largest CDMO Site

Hamilton, Ontario – September 09, 2026 -- AtomVie Global Radiopharma has opened a new $160 million manufacturing facility in Hamilton, Ontario, that the company calls the largest single-site radiopharmaceutical CDMO plant in North America.

New 72,300-square-foot plant multiplies manufacturing capacity tenfold

The purpose-built facility at 10 Aeropark Boulevard spans 72,300 square feet and increases AtomVie's manufacturing capacity by more than ten times its previous output. The site is designed to handle low- to high-volume production runs and supports a continuous path from early-stage clinical development through commercial-scale manufacturing.

AtomVie Opens $160M Radiopharma Facility, Largest CDMO Site in North America

Hamilton, ON – September 09, 2026 -- AtomVie Global Radiopharma has opened a 72,300-square-foot manufacturing facility at 10 Aeropark Boulevard in Hamilton, Ontario, representing an investment exceeding $160 million and marking the largest single-site CDMO facility in North America for radiopharmaceutical development.

New site delivers more than tenfold increase in manufacturing capacity

The purpose-built facility supports low-to-high throughput production, enabling AtomVie to scale operations from early clinical development through commercial manufacturing for its partners. The company is targeting a workforce of more than 200 employees by the end of 2026 as the site ramps toward full operational capacity.